Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis that enables the company to genetically engineer proteins with new amino acid building blocks beyond the common twenty, enabling the biosynthesis of proteins with new physical, chemical and pharmacological properties. 

Biotechnology

Ambrx

Ambrx's headquarters in San Diego, CA, United States

Mark Janis

Douglas Pierce

Thuy le

Mike Tattory

Douglas Greene

Colin Hessel

Chaigneau Joyeux

Lilly Vukov

Patricia Bryant

Mingchao Kang

Darryl Z. L'Heureux

Johanna Acosta

Sunita Hack

Manan Patel

Mysore Ramprasad

Ricardo Burgos

Sigeng Chen

Jakob Dupont

Peter Schultz

Paul Maier

Stuart Lutzker

Stephen Glover

Mike Moyer

The Leadership Team at Ambrx is comprised of key executives who guide the company’s strategic direction and operational excellence in the development of innovative protein therapeutics. They oversee research, clinical development, regulatory compliance, financial management, and data science initiatives, ensuring alignment with Ambrx's mission to leverage advanced protein engineering for groundbreaking therapeutic solutions. By fostering collaboration across departments, the Leadership Team drives the company’s growth and success in the biopharmaceutical landscape.

Leadership Team

The Regulatory Affairs and Quality Assurance team at Ambrx is responsible for ensuring that the company’s innovative protein therapeutics meet regulatory standards and quality benchmarks throughout the product development lifecycle. This team collaborates with scientists and regulatory bodies to navigate compliance, oversee documentation, and maintain rigorous quality control processes, ultimately facilitating the safe and effective delivery of novel biopharmaceuticals to the market.

Regulatory Affairs and Quality Assurance

The Clinical Research and Development team at Ambrx is responsible for designing, implementing, and overseeing clinical trials to evaluate the safety and efficacy of innovative protein therapeutics. This multidisciplinary team collaborates on protocol development, regulatory submissions, and data management, while ensuring compliance with industry standards and best practices. Their collective expertise aims to advance Ambrx's pioneering therapies from the lab to clinical application, ultimately enhancing patient outcomes.

Clinical Research and Development

Ambrx

Org chart

Board & advisors

Teams

Leadership Team

Regulatory Affairs and Quality Assurance

Clinical Research and Development

Offices

Ambrx

Org chart

Board & advisors

Teams

Leadership Team

Regulatory Affairs and Quality Assurance

Clinical Research and Development

Offices

Related companies